lobbying_activities: 1373390

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
1373390	191f222c-deda-42e8-9651-4011daf45bf2	Q1	NOVO NORDISK INC.	284790	NOVO NORDISK INC.	2013	first_quarter	PHA	Issues regarding Pharmaceutical Traceability Enhancement Code (Rx TEC) Act and discussion draft on serialization (track and trace); S.622 -- Animal Drug and Animal Generic Drug User Fee Reauthorization Act of 2013 for amendments that would impact human drug user fees; issues regarding biosimilars; 340B	Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Executive Office of the President (EOP),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE		600000	0	0	2013-04-16T14:29:05.360000-04:00